{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:12:46Z","timestamp":1793326366286,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T00:00:00Z","timestamp":1561075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["DC000129"],"award-info":[{"award-number":["DC000129"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["DC006279"],"award-info":[{"award-number":["DC006279"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["DC012595"],"award-info":[{"award-number":["DC012595"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["DC014801"],"award-info":[{"award-number":["DC014801"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12865-019-0302-3","type":"journal-article","created":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T14:03:08Z","timestamp":1561125788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lack of the hyaluronan receptor CD44 affects the course of bacterial otitis media and reduces leukocyte recruitment to the middle ear"],"prefix":"10.1186","volume":"20","author":[{"given":"Hyun Woo","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Kurabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen F.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,21]]},"reference":[{"issue":"3","key":"302_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1542\/pir.31-3-102","volume":"31","author":"JM Gould","year":"2010","unstructured":"Gould JM, Matz PS. Otitis media. Pediatr Rev. 2010;31(3):102\u201316.","journal-title":"Pediatr Rev"},{"issue":"8","key":"302_CR2","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1517\/14656566.2014.903920","volume":"15","author":"NM Thomas","year":"2014","unstructured":"Thomas NM, Brook I. Otitis media: an update on current pharmacotherapy and future perspectives. Expert Opin Pharmacother. 2014;15(8):1069\u201383.","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"302_CR3","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1097\/INF.0b013e318154b24a","volume":"26","author":"E Leibovitz","year":"2007","unstructured":"Leibovitz E. The challenge of recalcitrant acute otitis media: pathogens, resistance, and treatment strategy. Pediatr Infect Dis J. 2007;26(10):S8\u201311.","journal-title":"Pediatr Infect Dis J"},{"key":"302_CR4","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1097\/INF.0000000000001216","volume":"35","author":"ME Pichichero","year":"2016","unstructured":"Pichichero ME. Ten-year study of acute otitis media in Rochester, NY. Pediatr Infect Dis J. 2016;35:1027\u201332.","journal-title":"Pediatr Infect Dis J"},{"key":"302_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ijporl.2017.07.009","volume":"100","author":"I Vojtek","year":"2017","unstructured":"Vojtek I, Nordgren M, Hoet B. Impact of pneumococcal conjugate vaccines on otitis media: a review of measurement and interpretation challenges. Int J Pediatr Otorhinolaryngol. 2017;100:174\u201382.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"3","key":"302_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1542\/pir.20-3-85","volume":"20","author":"KA Daly","year":"1999","unstructured":"Daly KA, Hunter LL, Giebink GS. Chronic otitis media with effusion. Pediatr Rev. 1999;20(3):85\u201393.","journal-title":"Pediatr Rev"},{"key":"302_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/adc.85.2.91","volume":"85","author":"KE Bennett","year":"2001","unstructured":"Bennett KE, Haggard MP, Silva PA, Stewart IA. Behaviour and developmental effects of otitis media with effusion into the teens. Arch Dis Child. 2001;85:91\u20135.","journal-title":"Arch Dis Child"},{"issue":"1","key":"302_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11882-015-0585-2","volume":"16","author":"A Kurabi","year":"2016","unstructured":"Kurabi A, Pak K, Ryan AF, Wasserman SI. Innate immunity: orchestrating inflammation and resolution of otitis media. Curr Allergy Asthma Rep. 2016;16(1):6.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"12","key":"302_CR9","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.molimm.2003.10.005","volume":"40","author":"B Beutler","year":"2004","unstructured":"Beutler B. Innate immunity: an overview. Mol Immunol. 2004;40(12):845\u201359.","journal-title":"Mol Immunol"},{"issue":"4","key":"302_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/intimm\/dxp017","volume":"21","author":"T Kawai","year":"2009","unstructured":"Kawai T, Akira S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol. 2009;21(4):317\u201337.","journal-title":"Int Immunol"},{"issue":"1","key":"302_CR11","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1600-065X.2008.00731.x","volume":"227","author":"NW Palm","year":"2009","unstructured":"Palm NW, Medzhitov R. Pattern recognition receptors and control of adaptive immunity. Immunol Rev. 2009;227(1):221\u201333.","journal-title":"Immunol Rev"},{"issue":"12","key":"302_CR12","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1086\/593213","volume":"198","author":"M Hernandez","year":"2008","unstructured":"Hernandez M, Leichtle A, Pak K, Ebmeyer J, Euteneuer S, Obonyo M, Guiney DG, Webster NJ, Broide DH, Ryan AF, Waasserman SI. Myeloid differentiation primary response gene 88 is required for the resolution of otitis media. J Infect Dis. 2008;198(12):1862\u20139.","journal-title":"J Infect Dis"},{"key":"302_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1471-2172-10-45","volume":"10","author":"A Leichtle","year":"2009","unstructured":"Leichtle A, Hernandez M, Pak K, Webster NJ, Wasserman SI, Ryan AF. The toll-like receptor adaptor TRIF contributes to otitis media pathogenesis and recovery. BMC Immunol. 2009;10:45.","journal-title":"BMC Immunol"},{"issue":"2","key":"302_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/1753425914526074","volume":"21","author":"A Kurabi","year":"2015","unstructured":"Kurabi A, Lee J, Wong C, Pak K, Hoffman HM, Ryan AF, Wasserman SI. The inflammasome adaptor ASC contributes to multiple innate immune processes in the resolution of otitis media. Innate Immun. 2015;21(2):203\u201314.","journal-title":"Innate Immun"},{"issue":"6","key":"302_CR15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.3109\/00016489609137941","volume":"116","author":"M Kamimura","year":"1996","unstructured":"Kamimura M, Himi T, Kataura A. Cell adhesion molecules of experimental otitis media in the rat. Acta Otolaryngol. 1996;116(6):857\u201362.","journal-title":"Acta Otolaryngol"},{"issue":"2","key":"302_CR16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.otohns.2003.09.025","volume":"130","author":"E Russo","year":"2004","unstructured":"Russo E, Smith CW, Friedman EM, Smith EO, Kaplan SL. Cell adhesion molecules and cytokines in middle ear effusions in children with or without recent acute otitis media. Otolaryngol Head Neck Surg. 2004;130(2):242\u20138.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"5","key":"302_CR17","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/0955-0674(94)90100-7","volume":"6","author":"L Sherman","year":"1994","unstructured":"Sherman L, Sleeman J, Herrlich P, Ponta H. Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol. 1994;6(5):726\u201333.","journal-title":"Curr Opin Cell Biol"},{"issue":"9","key":"302_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1177\/000348948909800915","volume":"98","author":"C Laurent","year":"1989","unstructured":"Laurent C, Hellstr\u00f6m S, Tengblad A, Lilja K. Hyaluronan in experimental serous and purulent otitis media. Ann Otol Rhinol Laryngol. 1989;98(9):736\u201340.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"5","key":"302_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1471-4914(01)01963-3","volume":"7","author":"E Pure","year":"2001","unstructured":"Pure E, Cuff CA. A crucial role for CD44 in inflammation. Trends Mol Med. 2001;7(5):213\u201321.","journal-title":"Trends Mol Med"},{"issue":"3","key":"302_CR20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1182\/blood-2009-12-259556","volume":"116","author":"T Yago","year":"2010","unstructured":"Yago T, Shao B, Miner JJ, Yao L, Klopocki AG, Maeda K, Coggeshall KM, McEver RP. E-selectin engages PSGL-1 and CD44 through a common signaling pathway to induce integrin alphaLbeta2-mediated slow leukocyte rolling. Blood. 2010;116(3):485\u201394.","journal-title":"Blood."},{"key":"302_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3389\/fimmu.2015.00182","volume":"6","author":"AR Jordan","year":"2015","unstructured":"Jordan AR, Racine RR, Hennig MJ, Lokeshwar VB. The role of CD44 in disease pathophysiology and targeted treatment. Front Immunol. 2015;6:182.","journal-title":"Front Immunol"},{"key":"302_CR22","first-page":"235","volume":"6","author":"M Z\u00f6ller","year":"2015","unstructured":"Z\u00f6ller M. CD44, Hyaluronan, the hematopoietic stem cell, and leukemia-initiating cells. Front Immunol. 2015;6:235.","journal-title":"Front Immunol"},{"issue":"3","key":"302_CR23","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.4049\/jimmunol.177.3.1932","volume":"177","author":"B Sarraj","year":"2006","unstructured":"Sarraj B, Ludanyi K, Glant TT, Finnegan A, Mikecz K. Expression of CD44 and L-selectin in the innate immune system is required for severe joint inflammation in the proteoglycan-induced murine model of rheumatoid arthritis. J Immunol. 2006;177(3):1932\u201340.","journal-title":"J Immunol"},{"issue":"9","key":"302_CR24","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/j.0906-6705.2005.00348.x","volume":"14","author":"A Gonda","year":"2005","unstructured":"Gonda A, Gal I, Szanto S, Sarraj B, Glant TT, Hunyadi J, Mikecz K. CD44, but not l-selectin, is critically involved in leucocyte migration into the skin in a murine model of allergic dermatitis. Exp Dermatol. 2005;14(9):700\u20138.","journal-title":"Exp Dermatol"},{"issue":"5338","key":"302_CR25","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1126\/science.278.5338.672","volume":"278","author":"HC DeGrendele","year":"1997","unstructured":"DeGrendele HC, Estess P, Siegelman MH. Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science. 1997;278(5338):672\u20135.","journal-title":"Science"},{"issue":"12","key":"302_CR26","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.4049\/jimmunol.173.12.7594","volume":"173","author":"AI Khan","year":"2004","unstructured":"Khan AI, Kerfoot SM, Heit B, Liu L, Andonegui G, Ruffell B, Johnson P, Kubes P. Role of CD44 and hyaluronan in neutrophil recruitment. J Immunol. 2004;173(12):7594\u201301.","journal-title":"J Immunol"},{"issue":"12","key":"302_CR27","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1073\/pnas.96.12.6896","volume":"96","author":"S Brocke","year":"1999","unstructured":"Brocke S, Piercy C, Steinman L, Weissman IL, Veromaa T. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci U S A. 1999;96(12):6896\u201301.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"302_CR28","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1189\/jlb.72.6.1133","volume":"72","author":"H Xu","year":"2002","unstructured":"Xu H, Manivannan A, Liversidge J, Sharp PF, Forrester JV, Crane IJ. Involvement of CD44 in leukocyte trafficking at the blood-retinal barrier. J Leukoc Biol. 2002;72(6):1133\u201341.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"302_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1164\/rccm.200608-1243OC","volume":"176","author":"S Katoh","year":"2007","unstructured":"Katoh S, Ishii N, Nobumoto A, Takeshita K, Dai SY, Shinonaga R, Niki T, Tominaga A, Yamauchi A, Hirashima M. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am J Respir Crit Care Med. 2007;176(1):27\u201335.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"302_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102739","volume":"9","author":"K Suzukawa","year":"2014","unstructured":"Suzukawa K, Tomlin J, Pak K, Chavez E, Kurabi A, Baird A, Wasserman SI, Ryan AF. A mouse model of otitis media identifies HB-EGF as a mediator of inflammation-induced mucosal proliferation. PLoS One. 2014;9(7):e102739.","journal-title":"PLoS One"},{"issue":"13","key":"302_CR31","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1182\/blood-2008-04-150383","volume":"112","author":"G Hutas","year":"2008","unstructured":"Hutas G, Bajnok E, Gal I, Finnegan A, Glant TT, Mikecz K. CD44-specific antibody treatment and CD44 deficiency exert distinct effects on leukocyte recruitment in experimental arthritis. Blood. 2008;112(13):4999\u20135006.","journal-title":"Blood."},{"issue":"7","key":"302_CR32","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1172\/JCI200112455","volume":"108","author":"CA Cuff","year":"2001","unstructured":"Cuff CA, Kothapalli D, Azonobi I, Chun S, Zhang Y, Belkin R, Yeh C, Secreto A, Assoian RK, Rader DJ, Pur\u00e9 E. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest. 2001;108(7):1031\u201340.","journal-title":"J Clin Invest"},{"issue":"11","key":"302_CR33","doi-asserted-by":"publisher","first-page":"6266","DOI":"10.4049\/jimmunol.0904160","volume":"184","author":"C Shi","year":"2010","unstructured":"Shi C, Velazquez P, Hohl TM, Leiner I, Dustin ML, Pamer EG. Monocyte trafficking to hepatic sites of bacterial infection is chemokine independent and directed by focal intercellular adhesion molecule-1 expression. J Immunol. 2010;184(11):6266\u201374.","journal-title":"J Immunol"},{"issue":"6","key":"302_CR34","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1016\/S0002-9440(10)64498-7","volume":"161","author":"Q Wang","year":"2002","unstructured":"Wang Q, Teder P, Judd NP, Noble PW, Doerschuk CM. CD44 deficiency leads to enhanced neutrophil migration and lung injury in Escherichia coli pneumonia in mice. Am J Pathol. 2002;161(6):2219\u201328.","journal-title":"Am J Pathol"},{"issue":"5","key":"302_CR35","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.2353\/ajpath.2010.100562","volume":"177","author":"GJ van der Windt","year":"2010","unstructured":"van der Windt GJ, Florquin S, de Vos AF, van't Veer C, Queiroz KC, Liang J, Jiang D, Noble PW, van der Poll T. CD44 deficiency is associated with increased bacterial clearance but enhanced lung inflammation during gram-negative pneumonia. Am J Pathol. 2010;177(5):2483\u201394.","journal-title":"Am J Pathol"},{"issue":"4","key":"302_CR36","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/labinvest.2010.206","volume":"91","author":"GJ van der Windt","year":"2011","unstructured":"van der Windt GJ, Hoogendijk AJ, de Vos AF, Kerver ME, Florquin S, van der Poll T. The role of CD44 in the acute and resolution phase of the host response during pneumococcal pneumonia. Lab Investig. 2011;91(4):588\u201397.","journal-title":"Lab Investig"},{"issue":"25","key":"302_CR37","doi-asserted-by":"publisher","first-page":"18265","DOI":"10.1074\/jbc.M606352200","volume":"282","author":"KR Taylor","year":"2007","unstructured":"Taylor KR, Yamasaki K, Radek KA, Di Nardo A, Goodarzi H, Golenbock D, Beutler B, Gallo RL. Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on toll-like receptor 4, CD44, and MD-2. J Biol Chem. 2007;282(25):18265\u201375.","journal-title":"J Biol Chem"},{"issue":"6","key":"302_CR38","doi-asserted-by":"publisher","first-page":"4235","DOI":"10.4049\/jimmunol.180.6.4235","volume":"180","author":"H Kawana","year":"2008","unstructured":"Kawana H, Karaki H, Higashi M, Miyazaki M, Hilberg F, Kitagawa M, Harigaya K. CD44 suppresses TLR-mediated inflammation. J Immunol. 2008;180(6):4235\u201345.","journal-title":"J Immunol"},{"issue":"2\u20133","key":"302_CR39","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.molimm.2009.08.026","volume":"47","author":"J Muto","year":"2009","unstructured":"Muto J, Yamasaki K, Taylor KR, Gallo RL. Engagement of CD44 by hyaluronan suppresses TLR4 signaling and the septic response to LPS. Mol Immunol. 2009;47(2\u20133):449\u201356.","journal-title":"Mol Immunol"},{"key":"302_CR40","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12864-015-1475-7","volume":"16","author":"M Hernandez","year":"2015","unstructured":"Hernandez M, Leichtle A, Pak K, Webster NJ, Wasserman SI, Ryan AF. The transcriptome of a complete episode of acute otitis media. BMC Genomics. 2015;16:259.","journal-title":"BMC Genomics"},{"issue":"9","key":"302_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005857","volume":"12","author":"S Bl\u00e4ttner","year":"2016","unstructured":"Bl\u00e4ttner S, Das S, Paprotka K, Eilers U, Krischke M, Kretschmer D, Remmele CW, Dittrich M, M\u00fcller T, Schuelein-Voelk C, Hertlein T, Mueller MJ, Huettel B, Reinhardt R, Ohlsen K, Rudel T, Fraunholz MJ. Staphylococcus aureus exploits a non-ribosomal cyclic dipeptide to modulate survival within epithelial cells and phagocytes. PLoS Pathog. 2016;12(9):e1005857.","journal-title":"PLoS Pathog"},{"key":"302_CR42","doi-asserted-by":"publisher","first-page":"W627","DOI":"10.1093\/nar\/gki443","volume":"33","author":"A Hsiao","year":"2005","unstructured":"Hsiao A, Ideker T, Olefsky JM, Subramaniam S. VAMPIRE microarray suite: a web-based platform for the interpretation of gene expression data. Nucl Acids Res. 2005;33:W627\u201332.","journal-title":"Nucl Acids Res"},{"key":"302_CR43","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.jaci.2005.07.026","volume":"116","author":"J Ebmeyer","year":"2005","unstructured":"Ebmeyer J, Furukawa M, Pak K, Ebmeyer U, Sudhoff H, Broide D, Ryan AF, Wasserman S. Role of mast cells in otitis media. J Allergy Clin Immunol. 2005;116:1129\u201335.","journal-title":"J Allergy Clin Immunol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-019-0302-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12865-019-0302-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12865-019-0302-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T17:29:19Z","timestamp":1694971759000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/s12865-019-0302-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,21]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["302"],"URL":"https:\/\/doi.org\/10.1186\/s12865-019-0302-3","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,21]]},"assertion":[{"value":"4 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were performed according to the recommendations of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health and carried out in strict accordance with an approved Institutional Animal Care and Use Committee (IACUC) protocol. All animal experiments employed the best efforts for minimizing animal suffering under general anesthesia according to the guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Ryan is a co-founder of Otonomy Inc., serves as a member of the Scientific Advisory Board, and holds an equity position in the company. The UCSD Committee on Conflict of Interest has approved this relationship. Otonomy, Inc. played no part in the research reported here. The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}